Ex-Rorer exec William Bliss to president of San Diego antisense R&D firm. Genta has acquired Bliss' dermatologicals start-up, New Jersey-based Bliss Pharmaceuticals. Bliss, who spent 20 years at Rorer before founding Bliss Pharmaceuticals last August, will be responsible for day-to-day operations at Genta. The first Bliss product, a topical psoriasis treatment, is expected to enter clinicals this summer.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth